Warenkorb -  AGBs -  Datenschutz -  Contact us   

Therapeutic Lipidology


DAVIDSON / TOTH / MAKI --- Neuerscheinung!!

Therapeutic Lipidology

689 Seiten, 2. Auflage, 2021
140 Abbildungen

  • Provides comprehensive coverage of all core aspects of clinical lipidology as well as relevant basic science and dyslipidemia management strategies
  • Updated to include new guidelines, novel therapeutic agents, and changes in the understanding of specific lipids/lipoproteins and cardiovascular disease risk
  • Highlights recent advances in the field such as novel biomarkers and the microbiome, genomics of cardiovascular risks, PCSK9 inhibitors, as well as imaging technologies and lipoprotein separation/measurement methodologies
The second edition of this important book provides an up-to-date and comprehensive overview of clinical lipidology. Brand new chapters focus on recent advances in the field including novel biomarkers and the microbiome, genomics of cardiovascular risks, PCSK9 inhibitors, imaging technologies, and epidemiology of atherosclerotic cardiovascular disease.

The book describes new guidelines, novel therapeutic agents, and changes in the understanding of specific lipoproteins and subclasses with regard to their relationships to cardiovascular disease risk. The second edition contains more than thirty chapters covering such topics as the history of lipidology, lipoprotein metabolism and vascular biology, disorders of lipid metabolism, lifestyle/dietary and pharmacologic management for dyslipidemia, the management of dyslipidemia in certain subgroups (e.g., women, children, older patients) and lipid testing, as well as an examination of other biomarkers and testing procedures related to atherosclerosis and cardiovascular disease.

The second edition of Therapeutic Lipidology is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in lipidology, cardiology, endocrinology, pharmacotherapy, and health promotion and disease prevention.

Table of Contents
  • 1. History of Lipidology.-
  • 2. Atherogenesis and Vascular Biology.-
  • 3. Genetic Disorders of Lipoprotein Metabolism.-
  • 4. Cardiovascular Genomics.-
  • 5. Epidemiology of Atherosclerotic Cardiovascular Disease.-
  • 6. Comparison of 2018 AHA-ACC Multi-Society Cholesterol Guidelines with 2013 ACC-AHA Cholesterol Guidelines.-
  • 7. The Low-Density Lipoprotein Cholesterol Hypothesis: An Update.-
  • 8. Triglyceride-rich Lipoprotein Cholesterol (Remnant Cholesterol) as a Therapeutic Target for Cardiovascular Disease Risk.-
  • 9. Medical Nutrition Therapy for Lipid and Lipoprotein Disorders.-
  • 10. Nutraceuticals and Lipid Management.-
  • 11. Pharmacology of Statins.-
  • 12. Management of Statin Intolerance.-
  • 13. Intestinally Active Therapies for Hypercholesterolemia: Ezetimibe, Bile Acid Resins and Plant Sterols.-
  • 14. Proprotein Convertase Subtilisin/Kexin Type 9: Functional Role in Lipid Metabolism and its Therapeutic Inhibition.-
  • 15. Management of Hypertriglyceridemia (Including Fibrates and n-3 Fatty Acids).-
  • 16. Pathophysiology and Management of Dyslipidemias Associated with Insulin-resistant States.-
  • 17. Therapeutic Management of Obesity.-
  • 18. High Density Lipoproteins.-
  • 19. Lipoprotein (a): Principles from Bench to Bedside.-
  • 20. Management of Homozygous Familial Hypercholesterolemia.-
  • 21. Lysosomal Acid Lipase Deficiency.-
  • 22. Lipodystrophies.-
  • 23. HIV and Dyslipidemia.-
  • 24. Cardiovascular Disease in Women: Focus on Lipid Management.-
  • 25. Management of Dyslipidemia in the Elderly.-
  • 26. Management of Dyslipidemia in Children.-
  • 27. Lipoprotein Subfractions in Clinical Practice.-
  • 28. Ion Mobility Lipoprotein Analysis.-
  • 29. How ApoB Measurements Could Improve Prevention of Cardiovascular Disease.-
  • 30. C-reactive Protein and Other Inflammatory Markers in Cardiovascular Disease; Inflammatory Disorders and Atherosclerosis.-
  • 31. Coronary Artery Calcium and CT Angiography.-
  • 32. The Clinical Use of Ultrasound for Atherosclerosis Imaging.-
  • 33. Emerging Therapies for Regulating Dyslipidemias and Atherosclerosis.-
  • 34. The Allied Health Professional's Role in the Management of Dyslipidemia and Accreditation Council for Clinical Lipidology Certification Program.-
  • 35. The American Board of Clinical Lipidology Physician Certification Program.

Günstige Softcover Ausgabe der 1. Auflage 2021 Hardcover statt 235,39 €

€ 165,84
   
versandkostenfrei - in acht bis zehn Werktagen lieferbar Anzahl:
Preis: € 165,84